Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study).

Sixty SLE patients with only primary neuropsychiatric manifestations (NP-SLE), (54 female and six male; mean age 44.5) were compared consecutively. Forty-six of the patients (78.